Financial statements Nanochem
Balance sheet data of NANOCHEM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 17 016 036,73 | 14 738 975,76 | 19 313 438,19 | 24 843 091,74 | 29 914 083,86 |
| A. Fixed assets | 3 246 896,17 | 2 651 753,01 | 3 059 855,49 | 4 250 464,65 | 9 908 946,88 |
| B. Current assets | 13 769 140,56 | 12 087 222,75 | 16 253 582,70 | 20 592 627,09 | 20 005 136,98 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 17 016 036,73 | 14 738 975,76 | 19 313 438,19 | 24 843 091,74 | 29 914 083,86 |
| A. Equity | 6 812 604,91 | 9 913 922,53 | 10 853 016,22 | 12 591 987,81 | 15 501 131,76 |
| B. Liabilities and provisions for liabilities | 10 203 431,82 | 4 825 053,23 | 8 460 421,97 | 12 251 103,93 | 14 412 952,10 |
| I. Long-term liabilities | 1 218 231,61 | 969 326,37 | 734 237,97 | 2 790 540,31 | 461 848,52 |
| II. Short-term liabilities | 8 590 704,22 | 3 508 638,35 | 7 465 041,67 | 9 090 330,59 | 12 472 455,59 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.